CIK 0000313143
- Large accelerated filer
HAEMONETICS CORP
Sign in to watch- Ticker
- HAE
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Apr 3
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 042882273
- Phone
- +1 781-848-7100
- Business address
- 125 SUMMER STREET, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $101,148
- in 1 filing
Net −$101,148. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-05-15 | KROLL MARK W Director | Sale | −129 | $41.53 | $5K | 23,514 |
| 2017-05-15 | KROLL MARK W Director | Sale | −273 | $41.54 | $11K | 23,241 |
| 2017-05-15 | KROLL MARK W Director | Sale | −100 | $41.55 | $4K | 23,141 |
| 2017-05-15 | KROLL MARK W Director | Sale | −400 | $41.55 | $17K | 22,741 |
| 2017-05-15 | KROLL MARK W Director | Sale | −307 | $41.56 | $13K | 22,434 |
| 2017-05-15 | KROLL MARK W Director | Option exercise · Non-qualified Stock Option (Right to Buy) | −8,580 | 0 | ||
| 2017-05-11 | FOOTE SUSAN BARTLETT Director | Option exercise | +7,118 | $34.41 | $245K | 23,529 |
| 2017-05-11 | FOOTE SUSAN BARTLETT Director | Option exercise | +8,196 | $36.37 | $298K | 31,725 |
| 2017-05-11 | FOOTE SUSAN BARTLETT Director | Sale | −15,314 | $41.78 | $640K | 13,251 |
| 2017-05-11 | FOOTE SUSAN BARTLETT Director | Option exercise · Non-qualified Stock Option (Right to Buy) | −7,118 | 0 | ||
| 2017-05-11 | FOOTE SUSAN BARTLETT Director | Option exercise · Non-qualified Stock Option (Right to Buy) | −8,196 | 0 | ||
| 2017-03-24 | GELBMAN RONALD G Director | Option exercise | +8,580 | $27.24 | $234K | 58,268 |
| 2017-03-24 | GELBMAN RONALD G Director | Sale | −8,580 | $40.00 | $343K | 49,688 |
| 2017-03-24 | GELBMAN RONALD G Director | Option exercise · Non-qualified Stock Option (Right to Buy) | −8,580 | 0 | ||
| 2017-03-06 | Basil Michelle L EVP and General Counsel | Grant or award | +4,879 | $38.43 | $187K | 4,879 |
| 2017-03-06 | Basil Michelle L EVP and General Counsel | Grant or award · Non-qualified Stock Option (Right to Buy) | +19,490 | $38.43 | $749K | 19,490 |
| 2017-03-06 | Basil Michelle L EVP and General Counsel | Grant or award · Performance Shares | +9,758 | 19,516 | ||
| 2017-01-13 | Ryding Neil Mr. EVP, Global Manufacturing | Shares withheld for taxes | −3,303 | $40.32 | $133K | 16,022 |
| 2016-12-12 | GELBMAN RONALD G Director | Sale | −5,683 | $40.30 | $229K | 49,688 |
| 2016-10-25 | Goldstein Dan Chief Accounting Officer | Grant or award | +1,350 | 3,747 |
Page 44 of 47 · 929 trades